BLM

BLEOMYCIN A2

Find entries where: BLM

is present as a standalone ligand in 13 entries

as a non-polymer is covalently linked to polymer or other heterogen groups 1 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (Quick Screen)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	BLEOMYCIN A2
Synonyms	N1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE
Identifiers	n/a
Formula	C₅₅ H₈₅ N₁₇ O₂₁ S₃
Molecular Weight	1,416.56
Type	NON-POLYMER
Isomeric SMILES	Cc1c(nc(nc1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](c2c[nH]cn2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCS(C)C)O
InChI	InChI=1S/C55H85N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81,96H,7-13,15-16,56H2,1-6H3,(H2,57,76)(H2,59,82)(H2,60,88)(H,61,65)(H,62,84)(H,63,85)(H,66,87)(H,70,83)(H,71,86)(H2,58,69,72)/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1
InChIKey	ZGCQRJQBETWECF-UAPAGMARSA-N

Chemical Details
Formal Charge	0
Atom Count	181
Chiral Atom Count	19
Bond Count	186
Aromatic Bond Count	22

Drug Info: DrugBank

DrugBank ID	DB00290
Name	Bleomycin
Groups	investigational approved
Description	A complex of related glycopeptide antibiotics from <i>Streptomyces verticillus</i> consisting of bleomycin A2 and B2 (B2 CAS # 9060-10-0). It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. Bleomycin A2 is used as the representative structure for Bleomycin.
Synonyms	Bleomycin sulfate Bleomycin Bleomycinum Bleomicina Bleomycine Bleomicin Bleomycin hydrochloride Bleocin
Brand Names	Blenoxane Bleomycin for Injection Bleomycin for Injection USP Blenoxane Pws 15unit Bleomycin
Indication	For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.
Categories	Amino Acids, Peptides, and Proteins Antibiotics, Antineoplastic Antineoplastic Agents Antineoplastic and Immunomodulating Agents Carbohydrates Cardiotoxic antineoplastic agents Cytoprotective Agent Cytotoxic Antibiotics and Related Substances Drugs that are Mainly Renally Excreted Glycoconjugates Glycopeptides Immunosuppressive Agents Narrow Therapeutic Index Drugs Peptides
ATC-Code	L01DC01
CAS number	11056-06-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
DNA	-	unknown	cleavage
DNA ligase 1	MQRSIMSFFHPKKEGKAKKPEKEASNSSRETEPPPKAALKEWNGVVSESD...	unknown	inhibitor
DNA ligase 3	MSLAFKIFFPQTLRALSRKELCLFRKHHWRDVRQFSQWSETDLLHGHPLF...	unknown	inhibitor
Bleomycin hydrolase	MSSSGLNSEKVAALIQKLNSDPQFVLAQNVGTTHDLLDICLKRATVQRAQ...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682